But first, some science
Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Normally I dont learn article on blogs, but I wish to say that this write-up very forced me to check out and do it
The injection is subcutaneous, meaning it enters fatty tissue beneath your skin and distributes systemically throughout your bloodstream over several days
Mechanistically, GLP1RAs have a beneficial effect on different stroke risk factors, support microvascular function, and reduce inflammation and oxidative stress
The most effective peptides are Ipamorelin, CJC-1295, BPC-157 and Thymosin Beta 4